The Chinese National Health Commission said the epidemic situation of JN.1 in China remains low. But in the future, it may dominate the epidemic area. Due to many factors, such as the continuous spread from abroad and the travel of citizens before and after the New Year and Chinese New Year
In a statement issued by China's National Health Commission on Thursday (December 28), China is expected to continue to see a trend of outbreaks of respiratory diseases. This may be an outbreak of several types of infections at the same time or alternating between the current winter and the spring of next year 2024.
JN.1, a descendant of COVID-19, and the Omicron strain is now spreading rapidly in more than 40 countries, including the United States, France, Singapore and India. The WHO's initial risk assessment announcement on December 19 classified it as a “species of concern” and noted that it has a significant advantage in transmission over other strains.
Based on currently available evidence, JN.1 has been shown to evade immunity and increase its ability to spread disease. But the ability of germs to cause disease has not increased. The use of specific antiviral drugs is still effective in treatment. China reported a total of 490 people infected with the JN.1 virus across the country, including 47 people locally and 443 people who arrived from abroad, accounting for 90 percent.
In general, most of the respiratory diseases currently spreading in China are influenza. Mycoplasma infections have decreased and COVID-19 cases have decreased. At a low level, while medical services in various regions return to their normal seasonal levels.
The National Health Commission also urges people to maintain hygiene, wash their hands frequently, and maintain distance between the elderly and those with severe chronic diseases. Pregnant women should avoid crowded places.
Source: Global Times
“Subtly charming student. Pop culture junkie. Creator. Amateur music specialist. Beer fanatic.”